These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 6204435)

  • 1. The immunobiology of the feline leukemia virus.
    Rojko JL; Olsen RG
    Vet Immunol Immunopathol; 1984 May; 6(1-2):107-65. PubMed ID: 6204435
    [No Abstract]   [Full Text] [Related]  

  • 2. Determinants of susceptibility and resistance to feline leukemia virus infection. II. Susceptibility of feline lymphocytes to productive feline leukemia virus infection.
    Rojko JL; Hoover EA; Finn BL; Olsen RG
    J Natl Cancer Inst; 1981 Oct; 67(4):899-910. PubMed ID: 6268886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies from healthy cats exposed to feline leukemia virus lyse feline lymphoma cells slowly with cat complement.
    Grant CK; DeBoer DJ; Essex M; Worley MB; Higgins J
    J Immunol; 1977 Aug; 119(2):401-6. PubMed ID: 196021
    [No Abstract]   [Full Text] [Related]  

  • 4. Complement and tumor antibody levels in cats, and changes associated with natural feline leukemia virus infection and malignant disease.
    Grant CK; Pickard DK; Ramaika C; Madewell BR; Essex M
    Cancer Res; 1979 Jan; 39(1):75-81. PubMed ID: 216484
    [No Abstract]   [Full Text] [Related]  

  • 5. Lysis of feline lymphoma cells by complement-dependent antibodies in feline leukemia virus contact cats. Correlation of lysis and antibodies to feline oncornavirus-associated cell membrane antigen.
    Grant CK; Essex M; Pedersen NC; Hardy WD; Stephenson JR; Cotter SM; Theilen GH
    J Natl Cancer Inst; 1978 Jan; 60(1):161-6. PubMed ID: 203702
    [No Abstract]   [Full Text] [Related]  

  • 6. Feline leukemia - unique and cross-relating antigens on individual virus-producing tumors identified by complement-dependent antibody.
    Grant CK; Michalek MT
    Int J Cancer; 1981 Aug; 28(2):209-17. PubMed ID: 6172390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of cats against feline leukemia virus-positive and virus-negative tumors by complement-dependent antibody.
    Grant CK; Harris D; Essex ME; Pickard DK; Hardy WD; de Noronha F
    J Natl Cancer Inst; 1980 Jun; 64(6):1527-33. PubMed ID: 6246303
    [No Abstract]   [Full Text] [Related]  

  • 8. The occurrence of feline leukaemia virus neutralizing antibodies in cats.
    Russell PH; Jarrett O
    Int J Cancer; 1978 Sep; 22(3):351-7. PubMed ID: 212375
    [No Abstract]   [Full Text] [Related]  

  • 9. Biologic and immunologic response of cats to experimental infection with feline leukemia virus.
    Hoover EA; Olsen RG; Hardy WD; Schaller JP; Mathes LE; Cockerell GL
    Bibl Haematol; 1975 Oct; (43):180-3. PubMed ID: 183666
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody response in cats to feline leukemia virus reverse transcriptase under natural conditions of exposure to the virus.
    Jacquemin PC; Saxinger C; Gallo RC; Hardy WD; Essex M
    Virology; 1978 Dec; 91(2):472-6. PubMed ID: 84436
    [No Abstract]   [Full Text] [Related]  

  • 11. Infection with feline leukemia virus associated with induction of humoral response to a normal cell protein.
    Chen AP; Essex ME
    Cancer Invest; 1984; 2(2):81-90. PubMed ID: 6329486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response of healthy and leukemic cats to the feline oncornavirus-associated cell membrane antigen.
    Essex M; Hardy WD; Cotter SM; Jakowski RM
    Bibl Haematol; 1975; (40):483-8. PubMed ID: 169820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of antisera to oncornavirus glycoprotein (gp71) on infections of cats with feline leukemia virus.
    de Noronha F; Schäfer W; Essex M; Bolognesi DP
    Virology; 1978 Apr; 85(2):617-21. PubMed ID: 208242
    [No Abstract]   [Full Text] [Related]  

  • 14. Feline cytotoxic immune mechanisms against virus-associated leukemia and fibrosarcoma.
    McCarty JM; Grant CK
    Cell Immunol; 1983 Oct; 81(1):157-68. PubMed ID: 6311439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response to leukemia virus and tumor-associated antigens in cats.
    Essex M; Sliski A; Hardy WD; Cotter SM
    Cancer Res; 1976 Feb; 36(2 pt 2):640-5. PubMed ID: 56224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feline oncornavirus-associated cell membrane antigen. VI. Cytotoxic antibody in cats exposed to feline leukemia virus.
    Mathes LE; Yohn DS; Hoover EA; Essex M; Schaller JP; Olsen RG
    J Natl Cancer Inst; 1976 Jun; 56(6):1197-200. PubMed ID: 186623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of a tumour-specific antigen on the surface of feline lymphosarcoma cells.
    Snyder HW; Hardy WD; Zuckerman EE; Fleissner E
    Nature; 1978 Oct; 275(5681):656-8. PubMed ID: 212681
    [No Abstract]   [Full Text] [Related]  

  • 18. Killer cells of feline leukemia virus- and feline sarcoma virus-infected transformed cells: the role of NK, ADCC, and in vitro generated cytotoxic cells.
    Kooistra LH; Splitter GA
    Cell Immunol; 1985 Sep; 94(2):466-79. PubMed ID: 2992811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activation of feline complement by feline leukemia virus.
    Kobilinsky L; Hardy WD; Ellis R; Witkin SS; Day NK
    Infect Immun; 1980 Jul; 29(1):165-70. PubMed ID: 6249754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunopathology induced by the feline leukemia virus.
    Hardy WD
    Springer Semin Immunopathol; 1982; 5(1):75-106. PubMed ID: 6195744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.